《中华人民共和国药典》(简称《中国药典》)2020年版,本版药典收载品种5911种,新增319种,修订3177种,不再收载10种,因品种合并减少6种。一部中药收载2711种,其中新增117种、修订452种。二部化学药收载2712种,其中新增117种、修订2387种。三部生物制品收载153种,其中新增20种、修订126种:新增生物制品通则2个、总论4个。四部收载通用技术要求361个,其中制剂通则38个(修订35个大、检测方法及其他通则281个(新增35个、修订51个)、指导原则42个(新增12个、修订12个):药用辅料收载335种,其中新增65种、修订212种。(本书是《中国药典》的英文版)。
The Pharmacopoeia of the Peoples Republic of China 2020 Edition (referred to as the Chinese Pharmacopoeia), this edition of pharmacopoeia includes 5911 monographs, 319 new additions, 3177 revisions, 10 rejections, and 6 reductions due to the merger of monographs.
Volume I includes 2711 monographs of traditional Chinese medicines (TCMs), including 117 additions,and 452 revisions.
Volume II includes 2712 monographs of chemical drugs,i ncluding 117 additions, and 2387 revisions.
Volume III includes 153 monographs of biological products, including 20 additions, and 126 revisions: 2 general requirements and 4 general monographs of biological
products are newly added.
Volume IV includes 361 general technical requirements,including 38 general requirements for preparations (35 revisions),281 generaltesting methods and other general
chapters (35 additions,51 revisions),42guidelines (12 additions,12 revisions):335 monographs of pharmaceuticalexcipients,including 65 additions,and 212
revisions.(This book is the Englishversion of the Chinese Pharmacopoeia)